Non-traditional antibacterials in clinical pipeline globally by type 2021
In 2021, there were six antibacterials in the clinical pipeline worldwide using antibodies, while nine antibacterials were using bacterophage and phage-derived enzymes. This statistic illustrates the number of non-traditional antibacterials in the clinical pipeline worldwide, by mode of action.